NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic ® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month.

image for news LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

TOKYO & SANTA CRUZ, Calif.--(BUSINESS WIRE)---- $JOBY--ANA Holdings (ANA HD) and Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced a successful public flight demonstration of Joby's air taxi at the Expo 2025 Osaka, Kansai, Japan. The flight, the first of its kind at a world expo, included vertical takeoff, full transition to wingborne flight and vertical landing. It was conducted as part of Joby and ANA HD's plan to build a national.

image for news Joby, ANA Holdings Kickoff Next Phase of Air Taxi Development in Japan with Public Flight Demonstration at the Expo 2025 Osaka, Kansai, Japan

TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.

image for news BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity

LONDON & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, and home to the largest and most liquid energy markets in the world, today announced record open interest (OI) across its total futures markets of 56.8 million on September 25, 2025, with record OI of 43 million commodity futures and record OI of 41 million energy futures. ICE's oil futures markets reached record OI of 11 million on September 26, 2025, up.

image for news ICE's Total Futures Markets at Record Open Interest With Record Commodity and Energy Futures Open Interest

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a peer-reviewed manuscript in the Journal of Clinical Oncology - Precision Oncology (JCO PO). The paper features results from a multi-institutional study evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker for patients with germ cell tumors (GCT), including testicular cancer. Testicular cancer represents approximately 95% of all.

image for news Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced the appointment of Lisa Gurry as Chief Business Officer, effective immediately.

image for news GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bancorp announced that on Sept. 22, 2025, veteran wealth management leader Jodi Rolland joined the company as President, Affluent Wealth Management and will assume the role of CEO for U.S. Bancorp Investments (USBI) and U.S. Bancorp Advisors (USBA), with the effective date to be announced. In this role, Rolland oversees the nationwide network of U.S. Bank Wealth Management Affluent financial professionals of U.S Bank and its affiliates, USBI and USBA. Rolland.

image for news Jodi Rolland Joins U.S. Bank Wealth Management as President, Affluent Wealth Management

CrowdStrike Appoints Amjad Hussain as Chief Resilience Officer — Neutral

CRWD   Business Wire — September 30, 2025

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced the appointment of Amjad Hussain as chief resilience officer. Reporting directly to CEO and founder George Kurtz, Hussain will help shape how CrowdStrike advances resilience across its platform and business, accelerating CrowdStrike's defining principles of operational excellence and reliability across the company. He will also work across the cybersecurity ecosystem to raise the bar for resilience and help establish new.

image for news CrowdStrike Appoints Amjad Hussain as Chief Resilience Officer

First Citizens Appoints New Leadership in South Carolina and Georgia — Neutral

FCNCA   PRNewsWire — September 30, 2025

RALEIGH, N.C. , Sept. 30, 2025 /PRNewswire/ -- First Citizens Bank has named two new Area Executives in South Carolina and Georgia.

image for news First Citizens Appoints New Leadership in South Carolina and Georgia

IREN: Juggernaut In The Making — Positive

IREN   Seeking Alpha — September 30, 2025

IREN (IREN) is rapidly scaling datacenter capacity, leveraging vertical integration and standardized modular designs for unmatched efficiency and speed. IREN's AI cloud business is poised for significant growth, targeting $200–$250 million in annualized revenue, diversifying beyond its core Bitcoin mining operations. Strategic power procurement and secured 2.9 GW grid capacity position IREN for long-term cost advantages and scalable infrastructure expansion.

image for news IREN: Juggernaut In The Making

MENLO PARK, Calif. , Sept. 30, 2025 /PRNewswire/ -- A global study of multinational organizations' integration of agentic AI found that more than 68% of organizations will have integrated autonomous or semi-autonomous AI agents into their core operations by 2026.

image for news More Than 68% Percent of Organizations Expect to Have Integrated AI Agents By 2026, Protiviti Study Reveals

Best Income Stocks to Buy for September 30th — Positive

AEG  CNQ  ECO   Zacks Investment Research — September 30, 2025

ECO, CNQ and AEG made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 30, 2025.

image for news Best Income Stocks to Buy for September 30th

Warring: Nike is pretty well insulated from tariffs with its global business — Neutral

NKE   CNBC Television — September 30, 2025

Zachary Warring, Equity Research Analyst at CFRA, sees Nike's turnaround progressing but says high valuation limits upside, with holiday guidance key and market share gains still ahead.

image for news Warring: Nike is pretty well insulated from tariffs with its global business

NNN REIT: Is An Exciting Dividend Aristocrat Benefiting From Lower Rates — Positive

NNN   Seeking Alpha — September 30, 2025

NNN REIT is positioned for growth, as Fed rate cuts enhance its refinancing and acquisition opportunities, supporting capital appreciation and income. NNN's robust Q2 results, high occupancy (98%), and disciplined acquisition strategy drive steady FFO and dividend growth, with a 34-year dividend increase streak. NNN trades at attractive valuations (12.5x FFO, 9.84x EBITDA), below peers, and offers a 5.66% dividend yield, with strong coverage, making it compelling for income investors.

image for news NNN REIT: Is An Exciting Dividend Aristocrat Benefiting From Lower Rates

ARLINGTON, Va.--(BUSINESS WIRE)---- $AVAV #AVAV--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) today announced the launch of capability enhancements for its Puma™ LE small unmanned aircraft system.

image for news AV Enhances Puma LE with Integrated Laser Target Designator and Universal Gimbal Kit for Precision Targeting and Effortless Multi-Mission Flexibility

Hong Kong, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Rich Sparkle Holdings Limited (“we”, “ANPA” or the “Company”) (Nasdaq: ANPA) is a company with limited liability incorporated under the laws of the British Virgin Islands (“BVI”) with no material operations of its own. The Company conduct its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (“ESG”) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through ANPA Financial Services Group …

image for news Rich Sparkle Holdings Limited Announces Unaudited Financial Results For The Six Months Ended March 31, 2025

New Strong Sell Stocks for September 30th — Negative

BLMN  CNM  JAKK   Zacks Investment Research — September 30, 2025

CNM, BLMN and JAKK have been added to the Zacks Rank #5 (Strong Sell) List on September 30, 2025.

image for news New Strong Sell Stocks for September 30th

BANX: Generates A High Risk-Adjusted Return Using A Niche Security — Positive

BANX   Seeking Alpha — September 30, 2025

ArrowMark Financial Corp offers unique exposure to Regulatory Capital Relief Securities, providing diversification and low correlation with traditional equity and bond markets. BANX has delivered strong risk-adjusted returns, with a 5-year compounded performance of 12.21% and a secure 8.19% yield, often boosted by special distributions. The fund's portfolio is primarily floating rate, reducing duration risk, and its NAV has shown resilience and steady growth even during banking sector turmoil.

image for news BANX: Generates A High Risk-Adjusted Return Using A Niche Security

Viomi Technology Co., Ltd Filed 2024 Annual Report on Form 20-F — Neutral

VIOT   GlobeNewsWire — September 30, 2025

GUANGZHOU, China, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the "Company") (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that the Company has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”) on September 30, 2025.

image for news Viomi Technology Co., Ltd Filed 2024 Annual Report on Form 20-F

Company updates sequence of OST-HER2 regulatory submissions, prioritizing UK MHRA conditional Marketing Authorisation Application (MAA) submission following positive August 2025 Scientific Advice Meeting feedback from UK MHRA In principle, UK MHRA accepts use of historical control arm to support conditional MAA UK MHRA conditional MAA and US FDA Biologics Licensing Application (BLA) submissions expected to be completed within 30 days of each other, between December 2025 and January 2026 Company to propose use of immune activation biomarker coupled with overall survival data as surrogate efficacy endpoint to support Accelerated Approval in Type C Meeting invited by FDA, following positive End …

image for news OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update